Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-06-03T02:23:48.271Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Assessment of Suicide Risk in Depressive Disorder

Published online by Cambridge University Press:  07 November 2014

William H. Coryell
Get access Rights & Permissions [Opens in a new window]

Abstract

Efforts to identify clinical risk factors for complete suicide through the follow-up of depressed patients have yielded relatively few robust predictors. Those identified by at least three studies are (in order of decreasing frequency) suicidal plans/attempts, male sex, being single or living alone, inpatient status, and hopelessness. Because the best established of these predictors has only modest sensitivity and specificity, the need for other robust tools is clear. A rich body of research has identified two biological risk factors for suicide in depressive disorder: hypothalamicpituitary-adrenal axis hyperactivity and deficits in serotonin function. Moreover, there is now considerable evidence that the dexamethasone suppression test and measures of serum cholesterol concentrations, respectively, may provide a clinically useful reflection of these two mechanisms. Observations that these measures appear to be additive, both with each other and with other clinical risk factors, indicate that a substantial improvement in the clinician's ability to assess suicide risk is possible.

Type
Review Articles
Information
CNS Spectrums , Volume 11 , Issue 6 , June 2006 , pp. 455 - 461
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Busch, KA, Fawcett, J, Jacobs, DG. Clinical correlates of inpatient suicide. J Clin Psychiatry. 2003;64:14–19.Google Scholar
2.Isacsson, G, Bergman, U, Rich, CL. Antidepressants, depression and suicide: an analysis of the San Diego study. J Affect Disord. 1994;32:277–286.Google Scholar
3.Murphy, GE, Wetzel, RD, Robins, E, McEvoy, L. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry. 1992;49:459–463.Google Scholar
4.Young, EA, Coryell, W. Suicide and the hypothalamic-pituitary-adrenal axis. Lancet. 2005;366:959–961.Google Scholar
5.Beck, AT, Hermann, I, Schuyler, D. Development of suicide intent scores. In: Beck, AT, Resnick, HLP, Lettieri, DJ, eds. The Prediction of Suicide. Bowes, Md: Charles Press; 1974:45–56.Google Scholar
6.Hjelmeland, H, Stiles, TC, Bille-Brahe, U, Ostamo, A, Salender-Renberg, E, Wasserman, D. The value of suicide intent and various motives as predictors for future suicidal behavior. Arch Suicide Res. 1998;4:209–225.Google Scholar
7.Harriss, L, Hawton, K. Suicidal intent in deliberate self-harm and the risk of suicide: the predictive power of the Suicide Intent Scale. J Affect Disord. 2005;86:225–233.Google Scholar
8.Nimeus, A, Alsen, M, Traskman-Bendz, L. High suicidal intent scores indicate future suicide. Arch Suicide Res. 2002;6:211–219.Google Scholar
9.Spitzer, RL, Endicott, J. Schedule for Affective Disorders and Schizophrenia. New York, NY: New York State Psychiatric Institute; 1978.Google Scholar
10.Coryell, W, Young, EA. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry. 2005;66:412–417.Google Scholar
11.Angst, F, Stassen, HH, Clayton, PJ, Angst, J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord. 2002;68:167–181.CrossRefGoogle ScholarPubMed
12.Barraclough, BM, Pallis, DJ. Depression followed by suicide: a comparison of depressed suicides with living depressives. Psychol Med. 1975;5:55–61.Google Scholar
13.Bradvik, L, Berglund, M. Risk factors for suicide in melancholia. A case-record evaluation of 89 suicides and their controls. Acta Psychiatr Scand. 1993;87:306–311.Google Scholar
14.Bradvik, L, Berglund, M. Late mortality in severe depression. Acta Psychiatr Scand. 2001;103:111–116.Google Scholar
15.Fawcett, J, Scheftner, W, Clark, D, Hedeker, D, Gibbons, R, Coryell, W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiatry. 1987;144:35–40.Google Scholar
16.Fawcett, J, Scheftner, WA, Fogg, L, et al.Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147:1189–1194.Google Scholar
17.Maser, JD, Akiskal, HS, Schlettler, P, et al.Can temperament identify affectively ill patients who complete or seriously attempt suicide? A fourteen year prospective study. Suicide Life Threat Behav. 2002;32:10–32.Google Scholar
18.Fowler, RC, Tsuang, MT, Kronfol, Z. Communication of suicidal intent and suicide in unipolar depression. A forty year follow-up. J Affect Disord. 1979;1:219–225.CrossRefGoogle Scholar
19.Goldstein, RB, Black, DW, Nasrallah, A, Winokur, G. The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry. 1991;48:418–422.Google Scholar
20.Modestin, J, Kopp, W. A study of clinical suicide. J Nerv Ment Dis. 1988;176:668–674.Google Scholar
21.Nordstrom, P, Asberg, M, Aberg-Wistedt, A, Nordin, C. Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatr Scand. 1995;92:345–350.Google Scholar
22.Roy, A. Suicide in depressives. Compr Psychiatry. 1983;24:487–491.CrossRefGoogle ScholarPubMed
23.Schneider, B, Philipp, M, Muller, MJ. Psychopathological predictors of suicide in patients with major depression during a 5-year follow-up. Eur Psychiatry. 2001;16:283–288.Google Scholar
24.Sinclair, JM, Harriss, L, Baldwin, DS, King, EA. Suicide in depressive disorders: a retrospective case-control study of 127 suicides. J Affect Disord. 2005;87:107–113.CrossRefGoogle ScholarPubMed
25.Hoyer, EH, Olesen, AV, Mortensen, PB. Suicide risk in patients hospitalised because of an affective disorder: a follow-up study, 1973–1993. J Affect Disord. 2004;78:209–217.Google Scholar
26.Kessing, LV. Subtypes of depressive episodes according to ICD-10: prediction of risk of relapse and suicide. Psychopathology. 2003;36:285–291.Google Scholar
27.Newman, SC, Bland, RC. Suicide risk varies by subtype of affective disorder. Acta Psychiatr Scand. 1991;83:420–426.Google Scholar
28.Glassman, AH, O'Connor, CM, Califf, RM, et al.Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709.Google Scholar
29.Gladstone, GL, Mitchell, PB, Parker, G, Wilhelm, K, Austin, MP, Eyers, K. Indicators of suicide over ten years in a specialist mood disorders unit sample. J Clin Psychiatry. 2001;62:945–951.Google Scholar
30.Dorovini-Zis, K, Zis, AP. Increased adrenal weight in victims of violent suicide. Am J Psychiatry. 1987;144:1214–1215.Google Scholar
31.Szigethy, E, Conwell, Y, Forbes, NT, Cox, C, Caine, ED. Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry. 1994;36:374–380.Google Scholar
32.Dumser, T, Barocka, A, Schubert, E. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol. 1998;19:72–76.Google Scholar
33.Nemeroff, CB, Krishnan, RR, Reed, D, Leder, R, Beam, C, Dunnick, NR. Adrenal gland enlargement in major depression; a computed tomographic study. Arch Gen Psychiatry. 1992;49:384–387.Google Scholar
34.Arato, M, Banki, CM, Bissette, G, Nemeroff, CB. Elevated CSF CRF in suicide victims. Biol Psychiatry. 1989;25:355–359.Google Scholar
35.Raadsheer, FC, Hoogendijk, WJ, Stam, FC, Tilders, FJ, Swaab, DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994;60:436–444.Google Scholar
36.Lopez, JF, Palkovits, M, Arato, M, Mansour, A, Akil, H, Watson, SJ. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology. 1992;56:491–501.CrossRefGoogle ScholarPubMed
37.Nemeroff, CB, Owens, MJ, Bissette, G, Andorn, AC, Stanley, M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 1988;45:577–579.Google Scholar
38.Black, DW, Monahan, PO, Winokur, G. The relationship between DST results and suicidal behavior. Ann Clin Psychiatry. 2002;14:83–88.CrossRefGoogle ScholarPubMed
39.Coryell, W, Schlesser, M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry. 2001;158:748–753.Google Scholar
40.Coryell, W, Young, E, Carroll, B. HPA-axis hyperactivity in mortality in major depressive disorder. Psychiatry Res. In press.Google Scholar
41.Coryell, W, Schlesser, M. Combined biological tests for suicide prediction. Psychiatry Res. In press.Google Scholar
42.Mann, JJ, Brent, DA, Arango, V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology. 2001;24:467–477.Google Scholar
43.Stanley, B, Molcho, A, Stanley, M, et al.Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry. 2000;157:609–614.Google Scholar
44.Coccaro, EF, Kavoussi, RJ, Cooper, TB, Hauger, RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry. 1997;164:1430–1435.Google Scholar
45.Michaelis, BH, Goldberg, JF, Davis, GP, Singer, TM, Garno, JL, Wenze, SJ. Dimensions of impulsivity and aggression associated with suicide attempts among bipolar patients: a preliminary study. Suicide Life Threat Behav. 2004;34:172–176.Google Scholar
46.Swann, AC, Dougherty, DM, Pazzaglia, PJ, Pham, M, Steinberg, JL, Moeller, FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005;162:1680–1687.Google Scholar
47.Dumais, A, Lesage, AD, Lalovic, A, et al.Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry. 2005;162:1375–1378.Google Scholar
48.Delva, NJ, Matthews, DR, Cowen, PJ: Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs. Biol Psychiatry. 1996;39:100–106.Google Scholar
49.Steegmans, PH, Fekkes, D, Hoes, AW, Bak, AA, van der Does, E, Grobbee, DE. Low serum cholesterol concentration and serotonin metabolism in men. BMJ. 1996;312:221.Google Scholar
50.Terao, T, Yoshimura, R, Ohmori, O, et al.Effect of serum cholesterol levels on metachlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biol Psychiatry. 1997;41:974–978.Google Scholar
51.Vevera, J, Fisar, Z, Kvasnicka, T, et al.Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005;133:197–203.Google Scholar
52.Muldoon, MF, Kaplan, JR, Manuck, SB, Mann, JJ. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry. 1992;31:739–742.Google Scholar
53.Kaplan, JR, Shively, CA, Fontenot, MB, et al.Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med. 1994;56:479–484.Google Scholar
54.Ormiston, T, Wolkowitz, OM, Reus, VI, Manfredi, F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics. 2003;44:412–414.Google Scholar
55.Garland, M, Hickey, D, Corvin, A, et al.Total serum cholesterol in relation to psychological correlates in parasuicide. Br J Psychiatry. 2000;177:77–83.Google Scholar
56.Guillem, E, Pelissolo, A, Notides, C, Lepine, JP. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Res. 2002;112:83–88.CrossRefGoogle ScholarPubMed
57.Kunugi, H, Takei, N, Aoki, H, Nanko, S. Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997;41:196–200.Google Scholar
58.Papassotiropoulos, A, Hawellek, B, Frahnert, C, Rao, GS, Rao, ML. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry. 1999;32:1–4.Google Scholar
59.Gallerani, M, Manfredini, R, Caracciolo, S, Scapoli, C, Molinari, S, Fersini, C. Serum cholesterol concentrations in parasuicide. BMJ. 1995;310:1632–1636.Google Scholar
60.Sarchiapone, M, Roy, A, Camardese, G, De Risio, S. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord. 2000;61:69–71.Google Scholar
61.Tripodianakis, J, Markianos, M, Sarantidis, D, Agouridaki, M. Biogenic amine turnover and serum cholesterol in suicide attempt. Eur Arch Psychiatry Clin Neurosci. 2002;252:38–43.CrossRefGoogle ScholarPubMed
62.Alvarez, JC, Cremniter, D, Lesieur, P, et al.Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry. 1999;45:1066–1069.Google Scholar
63.Kim, YK, Myint, AM. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord. 2004;81:161–166.Google Scholar
64.Modai, I, Valevski, A, Dror, S, Weizman, A. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J Clin Psychiatry. 1994;55:252–254.Google Scholar
65.Bocchetta, A, Chillotti, C, Carboni, G, Oi, A, Ponti, M, Del Zompo, M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand. 2001;104:37–41.Google Scholar
66.Ozer, OA, Kutanis, R, Agargun, MY, et al.Serum lipid levels, suicidality, and panic disorder. Compr Psychiatry. 2004;45:95–98.CrossRefGoogle ScholarPubMed
67.Atmaca, M, Kuloglu, M, Tezcan, E, Semercioz, A. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res. 2002;14:502–505.CrossRefGoogle ScholarPubMed
68.Atmaca, M, Kuloglu, M, Tezcan, E, Ustundag, B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand. 2003;108:208–214.Google Scholar
69.Favaro, A, Caregaro, L, Di Pascoli, L, Brambilla, F, Santonastaso, P. Total serum cholesterol and suicidality in anorexia nervosa. Psychosom Med. 2004;66:548–552.Google Scholar
70.Alvarez, JC, Cremniter, D, Gluck, N, et al.Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res. 2000;95:103–108.Google Scholar
71.Ellison, LF, Morrison, HI. Low serum cholesterol concentration and risk of suicide. Epidemiology. 2001;12:168–172.Google Scholar
72.Lindberg, G, Rastam, L, Gullberg, B, Eklund, GA. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ. 1992;305:277–279.Google Scholar
73.Zureik, M, Courbon, D, Ducimetiere, P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ. 1996;313:649–651.Google Scholar
74.Carroll, BJ, Greden, JF, Feinberg, M. Suicide, neuroendocrine dysfunction and CSF5-HIAA con-centrations in depression. In: Angrist, B, ed. Recent Advances in Neuropsychopharmacology: Proceedings of 12th CINPCongress. Oxford, England: Pergoman Press; 1980:307–313.Google Scholar
75.Roy, A, Jimerson, DC, Pickar, D. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Am J Psychiatry. 1986;143:846–851.Google Scholar
76.Boza, RA, Milanes, FJ, Llorente, M, Reisch, J, Slater, VL, Garrigo, L. The DST and suicide among depressed alcoholic patients. Am J Psychiatry. 1988;145:266–267.Google ScholarPubMed
77.Coryell, W, Schlesser, MA. Suicide and the dexamethasone suppression test in unipolar depression. Am J Psychiatry. 1981;138:1120–1121.Google Scholar
78.Yerevanian, BI, Feusner, JD, Koek, RJ, Mintz, J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord. 2004;83:103–108.Google Scholar
79.Norman, WH, Brown, WA, Miller, IW, Keitner, Gl, Overholser, JC. The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand. 1990;81:120–125.Google Scholar
80.Nielsen, J, Bostwick, JM. The dexamethasone suppression test as a predictor of suicide risk. Mayo Clin Proc. In press.Google Scholar
81.Fawcett, J, Busch, KA, Jacobs, D, Kravitz, HM, Fogg, L. Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci. 1997;836:288–301.CrossRefGoogle ScholarPubMed
82.Zimmerman, M, Coryell, W, Pfohl, B, Stangl, D. An American validation study of the Newcastle Diagnostic Scale. II. Relationship with clinical, demographic, familial and psychosocial features. Br J Psychiatry. 1987;150:526–532.Google Scholar
83.Oquendo, MA, Russo, SA, Underwood, MD, et al.Higher postmortem prefrontal 5-HT(2A) receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry. 2006;59:235–243.Google Scholar
84.Dougherty, DM, Mathias, CW, Marsh, DM, Papageorgiou, TD, Swann, AC, Moeller, FG. Laboratory measured behavioral impulsivity relates to suicide attempt history. Suicide Life Threat Behav. 2004;34:374–385.Google Scholar